Safety, Tolerability, & Immunogenicity of a Polyvalent Pneumococcal

See also
Status	Clinical Trial	Phase
Completed	`NCT02463539` - Residual Anti-pneumococcal Immunity After Pneumococcal Immunization in ANCA-associated Vasculitis	N/A
Completed	`NCT03095326` - Pneumococcal Vaccination for Splenectomised Thalassemia Major Patients in Indonesia	Phase 4
Completed	`NCT02260882` - Revaccination With PNEUMOVAX™ 23 in Older Japanese Adults (V110-902)	Phase 4
Completed	`NCT02572635` - A Phase I Study to Evaluate the Safety and Immunogenicity of PnuBioVax	Phase 1
Completed	`NCT01654263` - A Phase IIb, Open-Label, Dose Ranging Study of 13-Valent Pneumococcal Conjugate Vaccine in Adults 55 Through 74 Years of Age Previously Vaccinated With 23-Valent Pneumococcal Polysaccharide Vaccine	Phase 2
Completed	`NCT01531322` - A Study Assessing 13-valent Pneumococcal Conjugate Vaccine in Healthy Chinese Subjects	Phase 1
Completed	`NCT00496093` - Safety, Tolerability and Immunogenicity of Pneumovax 23 in Healthy Adults in India (V110-011)	Phase 3
Completed	`NCT02062281` - Study of Evaluating Safety and Immunogenicity of 23-Valent Pneumococcal Polysaccharide Vaccine With Influenza Vaccine in Children and Adults	Phase 4
Completed	`NCT00133549` - 9-valent CRM 197 Pneumococcal	Phase 2
Completed	`NCT03467984` - A Study to Evaluate the Safety and Immunogenecity of LBVE(Multivalent Pneumococcal Conjugate Vaccine) in Healthy Infants	Phase 2
Active, not recruiting	`NCT03489018` - The Effect of Fractional Doses of Pneumococcal Conjugate Vaccines on Immunogenicity and Carriage in Kenyan Infants	Phase 4
Recruiting	`NCT02463578` - Immunogenicity of a Combined Anti-pneumococcal Vaccine Schedule in Patients With ANCA-associated Vasculitis	N/A
Completed	`NCT00535730` - ZOSTAVAX™ Administered Concomitantly With PNEUMOVAX™ 23 (V211-012)(COMPLETED)	Phase 3
Completed	`NCT02558751` - Pneumonia Vaccine in Aging HIV Positive Individuals	Phase 0
Completed	`NCT02515240` - Immune Response to Pneumococcal Vaccination in HIV Infected Individuals	Phase 0
Completed	`NCT00560950` - Revaccination With PNEUMOVAX(TM) 23 in Older Adults (V110-007)	Phase 3
Completed	`NCT05425732` - Safety and Immunogenicity of V116 in Pneumococcal Vaccine-naïve Adults (V116-003, STRIDE-3)	Phase 3
Completed	`NCT03619252` - Pneumococcal Vaccination of Multiple Myeloma Patients on Novel Agents	Phase 4
Not yet recruiting	`NCT03549208` - A Study to Evaluate the Safety and Immunogeneicity of Multivalent Pneumococcal Conjugate Vaccine in Healthy Adults	Phase 1
Not yet recruiting	`NCT03341195` - Mobile Phone SMS Messages and Automated Calls in Improving Vaccine Coverage Among Children in Pakistan	N/A

NCT number	NCT04665050
Study type	Interventional
Source	Merck Sharp & Dohme LLC
Contact
Status	Completed
Phase	Phase 1
Start date	February 4, 2021
Completion date	April 6, 2021

Safety, Tolerability, and Immunogenicity of a Polyvalent Pneumococcal Conjugate Vaccine (V116) in Japanese Adults (V116-002)

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms